Cargando…

Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity

Calcium channel blockers (CCBs) are the most prescribed medications in clinical practice. These drugs treat many conditions, including migraine headaches, vasospasms, abnormal heart rhythms, and hypertension. This widespread use, however, has also been linked with the increased incidence of CCB toxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Afzal, Muhammad A, Ozgur, Sacide S, Tagliaferri, Ariana R, Bathobakae, Lefika, Shamoon, Fayez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132854/
https://www.ncbi.nlm.nih.gov/pubmed/37123796
http://dx.doi.org/10.7759/cureus.36762
_version_ 1785031475019644928
author Afzal, Muhammad A
Ozgur, Sacide S
Tagliaferri, Ariana R
Bathobakae, Lefika
Shamoon, Fayez
author_facet Afzal, Muhammad A
Ozgur, Sacide S
Tagliaferri, Ariana R
Bathobakae, Lefika
Shamoon, Fayez
author_sort Afzal, Muhammad A
collection PubMed
description Calcium channel blockers (CCBs) are the most prescribed medications in clinical practice. These drugs treat many conditions, including migraine headaches, vasospasms, abnormal heart rhythms, and hypertension. This widespread use, however, has also been linked with the increased incidence of CCB toxicity cases. CCB toxicity may be from accidental ingestion or iatrogenic. Patients may show signs of cardiovascular toxicity such as hypotension, bradyarrhythmia, coma, or even death. The treatment includes discontinuing the offending medication, securing the airway, and raising blood pressure. Herein, we report a rare case of a 40-year-old male with a history of uncontrolled hypertension and advanced kidney disease who experienced iatrogenic cumulative calcium channel blocker toxicity while switching CCB classes due to a hypertensive emergency with concomitant atrial flutter. Although uncommon in clinical practice, iatrogenic CCB toxicity is possible and equally lethal. Clinicians must be cautious when initiating these drugs, switching between oral and intravenous formulations, or switching from one class to another to avoid overdoses.
format Online
Article
Text
id pubmed-10132854
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-101328542023-04-27 Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity Afzal, Muhammad A Ozgur, Sacide S Tagliaferri, Ariana R Bathobakae, Lefika Shamoon, Fayez Cureus Cardiology Calcium channel blockers (CCBs) are the most prescribed medications in clinical practice. These drugs treat many conditions, including migraine headaches, vasospasms, abnormal heart rhythms, and hypertension. This widespread use, however, has also been linked with the increased incidence of CCB toxicity cases. CCB toxicity may be from accidental ingestion or iatrogenic. Patients may show signs of cardiovascular toxicity such as hypotension, bradyarrhythmia, coma, or even death. The treatment includes discontinuing the offending medication, securing the airway, and raising blood pressure. Herein, we report a rare case of a 40-year-old male with a history of uncontrolled hypertension and advanced kidney disease who experienced iatrogenic cumulative calcium channel blocker toxicity while switching CCB classes due to a hypertensive emergency with concomitant atrial flutter. Although uncommon in clinical practice, iatrogenic CCB toxicity is possible and equally lethal. Clinicians must be cautious when initiating these drugs, switching between oral and intravenous formulations, or switching from one class to another to avoid overdoses. Cureus 2023-03-27 /pmc/articles/PMC10132854/ /pubmed/37123796 http://dx.doi.org/10.7759/cureus.36762 Text en Copyright © 2023, Afzal et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Cardiology
Afzal, Muhammad A
Ozgur, Sacide S
Tagliaferri, Ariana R
Bathobakae, Lefika
Shamoon, Fayez
Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
title Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
title_full Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
title_fullStr Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
title_full_unstemmed Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
title_short Unique Case of Cardiogenic Shock in the Setting of Cumulative Calcium Channel Blocker Toxicity
title_sort unique case of cardiogenic shock in the setting of cumulative calcium channel blocker toxicity
topic Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10132854/
https://www.ncbi.nlm.nih.gov/pubmed/37123796
http://dx.doi.org/10.7759/cureus.36762
work_keys_str_mv AT afzalmuhammada uniquecaseofcardiogenicshockinthesettingofcumulativecalciumchannelblockertoxicity
AT ozgursacides uniquecaseofcardiogenicshockinthesettingofcumulativecalciumchannelblockertoxicity
AT tagliaferriarianar uniquecaseofcardiogenicshockinthesettingofcumulativecalciumchannelblockertoxicity
AT bathobakaelefika uniquecaseofcardiogenicshockinthesettingofcumulativecalciumchannelblockertoxicity
AT shamoonfayez uniquecaseofcardiogenicshockinthesettingofcumulativecalciumchannelblockertoxicity